Search

everythinglearnresearchcommunity

for

Search:↓

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Most children with alopecia areata have patchy hair loss and common trichoscopic features like yellow and black dots.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Hair loss is mainly caused by hormones, autoimmune issues, and chemotherapy, and needs more research for treatments.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Better diagnostic and treatment strategies are needed for acne keloidalis nuchae, especially in high-risk groups.

Almost half of the men with beard hair loss also developed scalp hair loss within a year.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

A new severe form of monilethrix syndrome includes hair loss, scalp itching, cataracts, and distinct facial features.

Dermoscopy is useful for diagnosing different types of hair loss.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

A 19-year-old female with alopecia universalis experienced total hair loss, and previous treatments were ineffective.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Corticosteroids may effectively regrow hair in Alopecia Totalis with manageable side effects.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Platelet-Rich Plasma (PRP) has potential benefits in plastic surgery, especially for skin grafts, wound healing, hair loss, mild Carpal Tunnel Syndrome, and TMJ disorders, but more research is needed to confirm its effectiveness.

Congenital atrichia with papular lesions causes permanent hair loss and skin bumps due to a gene mutation.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.